Ramesh Shankar Wednesday, December 25, 2024, 08:00 Hrs [IST] The Karnataka State Registered Pharmacists Organization has recently brought to the notice of ...

Evolution of pain management and active physiotherapy in digitalising world: Dr. Apoorva Shrivastava Wednesday, December 25, 2024, 08:00 Hrs [IST] In the rapidly evolving landscap ...

LEIBINGER, a global leader in coding and marking technology, is focusing on Brazil with key initiatives to improve service delivery and meet the demands of local industries. By working with ...

Idorsia Ltd has provided an update on the ongoing exclusive negotiations for the global rights to aprocitentan. On November 27, 2024, the company announced that it had entered exclusive negotiations ...

Aethlon Medical updates ability of its medical device ‘Hemopurifier’ to capture H5N1 Bird Flu: San Diego Tuesday, December 24, 2024, 18:00 Hrs [IST] Aethlon Medical, Inc, a me ...

Chola Mahendran elected president of TN PTA, MS Saravanan general secretary: Our Bureau, Chennai Tuesday, December 24, 2024, 16:15 Hrs [IST] The annual general body meeting of the ...

Venus Remedies partners with NSDC to pioneer workforce development through skill certification: Our Bureau, Mumbai Tuesday, December 24, 2024, 15:45 Hrs [IST] Venus Remedies Limit ...

European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine and integrated healthcare solutions, with a mission to empower individuals to take control of their health and ...

Radiopharm Theranostics gets HREC approval to start study of 177Lu-labelled RAD 202 for treatment of HER2-expressing solid tumours: Sydney Tuesday, December 24, 2024, 15:00 Hrs [I ...

Karnataka is probably the 14th state to have a Food and Drugs Administration (FDA) in the country. The FDA’s efficiency directly contributes to effective service delivery in healthcare, food and drug ...

Research published on 20th December, 2024 could help neurologists in the future prescribe personalised treatment to people living with multiple sclerosis (MS), after scientists studied more than half ...

UK MHRA grants conditional marketing authorisation to Italfarmaco’s givinostat to treat patients with Duchenne muscular dystrophy: United Kingdom Tuesday, December 24, 2024, 12: ...